Solventum Corp | SOLV - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Align Technology USD 757.43M 20.84M 2026-06
Baxter International USD 1.14B 251M 2026-06
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Cencora USD 6.37B 3.37B 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Insulet USD 562.6M 21.8M 2026-06
Solventum Corp USD 1.29B 189M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06